GlassScriptPhysician profile
Bianca N Shuster
NPI 1942853957
$7,929.29
in general payments reported to CMS, 2019-2025
47 companies · $904 in 2025
The $904 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,295 · 2022: $2,388 · 2023: $1,912 · 2024: $430 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,182 · Travel and Lodging: $979 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,182.19 |
| Travel and Lodging | $978.64 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,435.80 | 2022-2024 | Axonics |
| Abbvie INC. | $654.58 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $550.57 | 2021-2022 | |
| Astellas Pharma US INC | $475.26 | 2021-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $444.07 | 2021-2022 | |
| Lilly USA, LLC | $396.78 | 2021-2022 | |
| Novo Nordisk INC | $374.33 | 2021-2023 | Ozempic, Rybelsus |
| Pfizer INC. | $358.83 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $294.29 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Sumitomo Pharma America, INC. | $276.01 | 2023-2025 | Orgovyx, Gemtesa |
| Amgen INC. | $203.34 | 2021-2022 | |
| Eisai INC. | $183.27 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $178.44 | 2021-2022 | |
| Amarin Pharma, INC. | $174.67 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $172.81 | 2021-2022 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $163.12 | 2021-2022 | |
| Coloplast Corp | $145.53 | 2023-2025 | Speedicath |
| Urogen Pharma, INC. | $114.08 | 2024-2025 | |
| Tolmar, INC. | $107.23 | 2023-2025 | Jatenzo |
| Ferring Pharmaceuticals INC. | $101.52 | 2024-2025 | Adstiladrin |
| Heartflow, INC. | $93.21 | 2022 | |
| Antares Pharma, INC. | $87.97 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $81.26 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.14 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $77.61 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $75.29 | 2021 | |
| Myriad Genetic Laboratories, INC. | $75.16 | 2023-2024 | Prolaris |
| Immunitybio, INC. | $53.36 | 2025 | |
| Integra Lifesciences Corporation | $46.29 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Agiliti Surgical, INC. | $38.03 | 2025 | Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology, Coloplast Tfl Drive Laser, Olympus Soltive Tfl Laser |
| Urovant Sciences INC | $37.32 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $34.54 | 2021 | |
| Dentsply Ih INC. | $29.42 | 2022 | |
| Horizon Therapeutics Plc | $29.28 | 2021-2022 | |
| Olympus America INC. | $28.60 | 2023 | Itind System |
| Tempus Ai, INC | $27.20 | 2024 | Xt Cdx |
| Boston Scientific Corporation | $25.77 | 2024 | Rezum Generator |
| Procept Biorobotics Corporation | $25.19 | 2024 | Aquabeam System |
| 180 Medical, INC. | $24.99 | 2025 | |
| Alexion Pharmaceuticals, INC. | $24.40 | 2021 | |
| Mission Pharmacal Company | $23.91 | 2022 | |
| Xeris Pharmaceuticals, INC. | $21.22 | 2022 | |
| Calyxo, INC. | $19.82 | 2025 | Cvac Aspiration System |
| Azurity Pharmaceuticals, INC. | $18.87 | 2025 | Azmiro |
| Teleflex LLC | $18.03 | 2025 | Urolift |
| Sunovion Pharmaceuticals INC. | $14.96 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bianca Shuster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.